WP_Query Object
(
[query] => Array
(
[post_type] => post
[post_status] => publish
[orderby] => post__in
[order] => DESC
[ignore_sticky_posts] => 1
[post__not_in] => Array
(
[0] => 382
)
[post__in] => Array
(
[0] => 361
[1] => 367
[2] => 369
)
[posts_per_page] => 3
)
[query_vars] => Array
(
[post_type] => post
[post_status] => publish
[orderby] => post__in
[order] =>
[ignore_sticky_posts] => 1
[post__not_in] => Array
(
[0] => 382
)
[post__in] => Array
(
[0] => 361
[1] => 367
[2] => 369
)
[posts_per_page] => 3
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
=>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts
WHERE 1=1 AND wp_posts.ID IN (361,367,369) AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
ORDER BY FIELD(wp_posts.ID,361,367,369)
LIMIT 0, 3
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 361
[post_author] => 2
[post_date] => 2020-09-24 08:48:00
[post_date_gmt] => 2020-09-24 08:48:00
[post_content] =>
A post written by Jessica Shull (Digital Therapeutics Alliance), Dr. Keith Grimes (Babylon Health), and Alexandra Yembele (Withings). Last edit: October, 8th
Health systems are evolving beyond the doctor’s office
Countries aim to improve current standards of care for their populations while developing novel ways to treat patients with acute health conditions. This evolution has only quickened in the midst of a continuously shifting pandemic, and the result of this adaptation is the adoption of digital health technologies (DHT). Although DHT has been developing for the last 20 years, the physical dangers of being together during a pandemic has sped up the need for doctors to be able to collect actionable insights and extend care beyond the office setting. The advances in DHT could offer integrated care for whole populations in countries across the globe while providing tools so that potentially, no one is left behind.
New solutions for new challenges
There are several examples that show how healthcare systems are adopting innovative pathways for DHTs. Three examples include:
- Regulatory authorities in Germany have now approved digital therapies and diagnostics which may be prescribed nationally to 78 million people;
- As part of insurance benefits in some countries, employers are utilizing connected devices like sleep trackers and heart rate monitors to encourage employees to improve health indicators;
- In 2019, few physicians in Germany utilized telemedicine platforms (virtual visits with patients via phone or online), but this year there was a 200% increase in some parts of the country due to the pandemic.
These examples highlight countries’ need to find new ways to interact with patients and provide care within existing healthcare systems.
The best-case scenario is when these three resources — digital therapeutics, remote patient monitoring, and telemedicine platforms — work together. This trio of digital health technologies can be used to assist a wide variety of patients including those who have for example, hypertension, diabetes, implant receivers, and or COPD.
The ideal DHT Combination
The European Respiratory Society estimates 15–20% of adults over 40 in Europe suffer from this Chronic Obstructive Pulmonary Disease (COPD). A typical patient, who we’ll call Maria, might visit a doctor every six months for routine COPD checkups, but collecting data biannually may not provide the information needed to see important health trends and anticipate potential complications. Rather than relying on these infrequent visits, COPD patients could access the benefits of DHT via digital care products to manage the disease.
Firstly, this type of patient needs access to personal medical devices that can actively monitor health at home or on the go. The Withings ScanWatch is an example of a connected device that can monitor this patient’s oxygen saturation and daily walking distance multiple times a day rather than the typical protocol, which is to wait six months to measure indicators in hospital. The next step towards DHT solutions entails the bridge between patients’ data and medical providers. The backend integration of Withings’ open API allows Babylon, a telemedicine platform, to automatically and safely receive data that patients have authorized to be sent. Medical providers would then have on-demand access to the data and can adjust this patient’s medications accordingly while also monitoring the long-term effectiveness of treatment.
In addition to the medical device and telemedicine bridge between patient and provider, using a companion digital therapeutics (DTx) for COPD could help improve patient outcomes. The DTx is clinically-validated, works with medications, tracks triggers that reduce oxygen levels, and helps adjust key behaviors to optimize overall condition. Due to the insights provided via the DTx, COPD patients can avoid taking walks on days with high levels of air pollution, lower the use of rescue inhalers, understand how to best exercise, and experience reduced dyspnoea episodes.
The combination of device, telemedicine, and DTx is a suite of technologies composing DHT that can help patients and providers co-create care plans that help identify goals and well-defined actions to improve health and change key behaviors. While patients can still check in every 6 months with providers, data is being delivered more frequently which could reduce hospital visits and deliver better health indicators.
However, dumping large amounts of patient vitals every day is not the answer, which is why providers can enable a series of alerts that initiate a clinician review based on patient triggers revolving around personal conditions and health history. In this case, doctors only see the information that is needed, not daily dumps of data.
Who are the DHT minds behind this article?
Babylon Health
Babylon Health is a globally leading technology company with the ambitious mission to put an accessible and affordable health service in the hands of every person on Earth. We combine technology and medical expertise to bring doctors and people closer together, with digital health tools designed to empower people with knowledge about their health. Through a range of digital health services — such as an AI-backed app and video doctor appointments — we provide around-the-clock access to affordable, holistic healthcare services and information. We work with governments, health providers and insurers across the globe, and healthcare facilities from small local practices to large hospitals. With a $2Bn valuation, Babylon covers 20 million people across the globe, and has delivered more than 8m virtual consultations and AI interactions. We have teamed up with 170 impactful worldwide partners — including Mount Sinai Health Partners, the NHS, Telus Health, the Bill & Melinda Gates Foundation and the Government of Rwanda — to fulfil our vision of accessible and affordable healthcare, for all. For more information, visit https://www.babylonhealth.com
Withings
Withings produces medical grade devices for at-home monitoring so that patients can understand with precision their symptoms and trends in indicators. Withings’ mission is to continuously and effortlessly provide healthcare professionals with medical-grade data generated by patients from an ecosystem of connected devices. For more than a decade, Withings has built a range of award-winning products including activity trackers, connected scales, a wireless blood pressure monitor, a smart temporal thermometer, and an advanced sleep system. From remote patient monitoring to clinical research to chronic disease management, Withings has dedicated solutions that provide the richest array of accurate real-world data thanks to a complete ecosystem of connected devices, data connectivity options, and a remote patient monitoring platform. Visit our website here.
Digital Therapeutics Alliance
Founded in 2017, the Digital Therapeutics Alliance (DTA) is a non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. DTA maintains an international industry focus and is headquartered in the United States. DTA exists to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare through education, advocacy, and research. In Europe, digital therapeutics offer regulated, CE marked digital therapies to patients with a diagnosed condition or disease. Most DTx products in Europe require third-party authorization or a prescription from a qualified clinician. Digital therapeutics undergo clinical trials, collect real world outcomes, and are based on patient-centered core principles and product development best practices, including product design, usability, data security, and privacy standards.
[post_title] => Evolution of the digital health spectrum of care
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => evolution-of-the-digital-health-spectrum-of-care
[to_ping] =>
[pinged] =>
[post_modified] => 2023-08-04 00:02:55
[post_modified_gmt] => 2023-08-04 00:02:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=361
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 367
[post_author] => 2
[post_date] => 2021-07-13 08:58:00
[post_date_gmt] => 2021-07-13 08:58:00
[post_content] =>
After detailing how to select the best remote patient monitoring for community health centers, we wanted to detail how Withings is uniquely qualified to help.
1. Cellular-enabled devices enhance patient usability and accessibility
Withings has introduced cellular-enabled devices that include the BPM Connect Pro blood pressure monitor and the Body Pro scale. These two devices remove technological barriers in the patient journey while making sure installation and use are frictionless at three levels:
- An extremely simple onboarding experience. Thanks to cellular connectivity, BPM Connect Pro and Body Pro work right out of the box, and no smartphone, tablet, or Wi-Fi is required.
- Easy-to-use devices, no app needed. The BPM Connect Pro has only one button to press. For the patient, results appear right on the device screen along with color-coded feedback based on American Heart Association recommendations. In the case of patients using scales, Body Pro only requires participants to step on the scale, and then data is seamlessly recorded with no buttons to press.
- Long battery life. BPM Connect Pro lasts six months before having to recharge it, and Body Pro scale lasts up to 12 months.
Our simplified user experience drives retention and long-term use among chronic patients with different digital literacies and connectivity capacities allowing community health centers to kickstart and maintain remote patient monitoring programs rather than spending time on device education.
2. Withings RPM integrates directly into existing EHR systems
Through the Withings partnership with Redox, Withings offers the possibility to integrate a new remote patient monitoring solution with many of the industry’s leading EHR management platforms. For limited RPM duration or smaller patient cohorts, EHR integration costs can be significant. Alternatively, Withings has developed MED·PRO CARE, a comprehensive solution that will help you to manage your RPM program from patient enrollment to data visualization in a modern, user-friendly platform. MED·PRO CARE has an economical model based on subscription to help community health centers master their investments while benefiting from a turnkey solution that saves time on IT development and implementation.
3. Withings helps community health centers save money
Did you know that opting for a cellular smart device could be up to 60% less expensive than buying a Bluetooth device and tablet? Withings cellular devices are meant to break barriers to access, and one barrier is cost. Saved expenses could be used to enroll more chronic patients in your RPM program or fund other telehealth investments.
4. Withings RPM has customer service built-in
Withings Customer Support team is a proud Golden Bridge Customer Support winner in the category of Customer Service and Support Team Department of the Year. In addition to excellent support, the Withings ecosystem of devices are incredibly easy for patients and providers to use, resulting in an exceptionally low contact rate. Finally, a dedicated customer success manager is assigned to each community health center to make sure Withings products and services address the center’s unique provider and patient needs.
Learn more about BPM Connect Pro and don’t hesitate to reach out to our team if you have questions, want samples, or need more info about potential RPM integration with your community health center.
[post_title] => 4 Ways Withings Can Help Community Health Centers Succeed with RPM
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => 4-ways-withings-can-help-community-health-centers-succeed-with-rpm
[to_ping] =>
[pinged] =>
[post_modified] => 2023-08-01 21:42:16
[post_modified_gmt] => 2023-08-01 21:42:16
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=367
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 369
[post_author] => 2
[post_date] => 2021-10-13 09:17:00
[post_date_gmt] => 2021-10-13 09:17:00
[post_content] =>
Refugees are a subset of the population that suffer displacement and other stressors, and once they reach their new home country, medical conditions including hypertension can go undetected and untreated. However, research into this very topic began in February 2021. The study entitled “Perceptions, Knowledge, and Attitudes Towards Hypertension Management among Refugees in San Diego” is being carried out by Dr. Tala Al-Rousan, a founding faculty member at the Herbert Wertheim School of Public Health at the University of California San Diego, in partnership with Dr. Job Godino who leads the Laura Rodriguez Research Institute at the Family Health Care Centers of San Diego.
Throughout the program, participants are using Withings BPM Connect, a smart blood pressure monitor, as well as the Withings Data Hub, a cellular gateway used to collect measurements. The study is funded by The National Heart, Lung, and Blood Institute of the US National Institutes of Health. It aims to contribute to a relatively small body of literature surrounding the unaddressed global challenge of uncontrolled blood pressure in displaced populations including refugees and asylum seekers. The problem of hypertension among displaced peoples is even more prevalent as the numbers of refugees continue to increase due to higher rates of violence, natural disasters, and health inequities.
A specific goal of the project is to examine the feasibility of self-administered blood pressure monitoring through supportive healthcare infrastructure. The study hopes to show preliminary data that refugee patients can and prefer to take leadership over their hypertension management from where they are residing in combination with receiving guidance on medication titration plans from their healthcare providers.
In combination with BPM Connect, Drs. Al-Rousan and Godino’s teams collect patient data using Withings remote patient monitoring (RPM) solution. Both device and RPM help solve several pain points that participants may face such as interrupted healthcare access, economic hardship, language barriers, and varying levels of health literacy and numeracy. Regarding interrupted access, going to the doctor can be difficult for participants as some may have employment that does not allow for brief leave from work; since the device can be used at home, less time needs to be budgeted. BPM Connect also uses one button to take measurements which reduces potential language and use factors. Finally, any question of whether participants can access the internet has been assuaged using Withings Data Hub, a cellular gateway that requires no installation from users and securely connects retrieved data to the Withings RPM solution without requiring a smartphone or Wi-Fi.
The study includes 80 Aramaic and Arabic-speaking refugees with diagnosed uncontrolled blood pressure. Participants were recruited in consultation with ethnic community-based organizations in San Diego that serve refugees including Al Majdal Center and others. Multicultural and multilingual investigators with expertise in refugee health, digital health, epidemiology, and chronic disease prevention are involved in the team.
The study asks participants to measure their blood pressure three times a day every other day for four weeks. Qualitative interviews are being conducted before and after the intervention period to understand the levels of acceptability of remote monitoring and whether participants feel more in control, empowered, aware, and engaged in better quality healthcare. Questions on the role of social networks in health education and medication adherence are also asked about in this study.
“This project is revolutionary in that it is the first of its kind to be addressing the unmet need of uncontrolled blood pressure, a silent killer to millions all over the world, in one of the most understudied and underserved populations which is the refugee population.” — Dr. Al-Rousan
An observation the team has noted in the program are the results of two randomized groups — one that receives in-person education about how to use BPM Connect and the other that receives the same education virtually. The virtual education group has not only received the intervention smoothly but actually preferred it over in-person instruction which may be explained by fears of contracting COVID, or simply convenience and saving on transportation and other costs. Additionally, the use of the BPM Connect has extended beyond the intended four-week intervention period.
The ongoing pandemic has highlighted health disparities that vulnerable populations face. Drs. Al-Rousan and Godino hope that this study will show how innovative digital health solutions fit within patients’ feelings of acceptance while displaying that taking healthcare to marginalized people’s homes enables these populations to relate to their health providers, engage in healthier behaviors, and better manage chronic diseases.
The study is now in the end phase and results will soon be published. For questions, please contact Dr. Tala Al-Rousan. To find out more about how institutions are using BPM Connect and other connected health devices with the Withings Data Hub, you can visit Withings.com.
[post_title] => Innovating Hypertension Management Amongst Refugees in San Diego
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => innovating-hypertension-management-amongst-refugees-in-san-diego
[to_ping] =>
[pinged] =>
[post_modified] => 2023-08-01 21:35:40
[post_modified_gmt] => 2023-08-01 21:35:40
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=369
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 3
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 361
[post_author] => 2
[post_date] => 2020-09-24 08:48:00
[post_date_gmt] => 2020-09-24 08:48:00
[post_content] =>
A post written by Jessica Shull (Digital Therapeutics Alliance), Dr. Keith Grimes (Babylon Health), and Alexandra Yembele (Withings). Last edit: October, 8th
Health systems are evolving beyond the doctor’s office
Countries aim to improve current standards of care for their populations while developing novel ways to treat patients with acute health conditions. This evolution has only quickened in the midst of a continuously shifting pandemic, and the result of this adaptation is the adoption of digital health technologies (DHT). Although DHT has been developing for the last 20 years, the physical dangers of being together during a pandemic has sped up the need for doctors to be able to collect actionable insights and extend care beyond the office setting. The advances in DHT could offer integrated care for whole populations in countries across the globe while providing tools so that potentially, no one is left behind.
New solutions for new challenges
There are several examples that show how healthcare systems are adopting innovative pathways for DHTs. Three examples include:
- Regulatory authorities in Germany have now approved digital therapies and diagnostics which may be prescribed nationally to 78 million people;
- As part of insurance benefits in some countries, employers are utilizing connected devices like sleep trackers and heart rate monitors to encourage employees to improve health indicators;
- In 2019, few physicians in Germany utilized telemedicine platforms (virtual visits with patients via phone or online), but this year there was a 200% increase in some parts of the country due to the pandemic.
These examples highlight countries’ need to find new ways to interact with patients and provide care within existing healthcare systems.
The best-case scenario is when these three resources — digital therapeutics, remote patient monitoring, and telemedicine platforms — work together. This trio of digital health technologies can be used to assist a wide variety of patients including those who have for example, hypertension, diabetes, implant receivers, and or COPD.
The ideal DHT Combination
The European Respiratory Society estimates 15–20% of adults over 40 in Europe suffer from this Chronic Obstructive Pulmonary Disease (COPD). A typical patient, who we’ll call Maria, might visit a doctor every six months for routine COPD checkups, but collecting data biannually may not provide the information needed to see important health trends and anticipate potential complications. Rather than relying on these infrequent visits, COPD patients could access the benefits of DHT via digital care products to manage the disease.
Firstly, this type of patient needs access to personal medical devices that can actively monitor health at home or on the go. The Withings ScanWatch is an example of a connected device that can monitor this patient’s oxygen saturation and daily walking distance multiple times a day rather than the typical protocol, which is to wait six months to measure indicators in hospital. The next step towards DHT solutions entails the bridge between patients’ data and medical providers. The backend integration of Withings’ open API allows Babylon, a telemedicine platform, to automatically and safely receive data that patients have authorized to be sent. Medical providers would then have on-demand access to the data and can adjust this patient’s medications accordingly while also monitoring the long-term effectiveness of treatment.
In addition to the medical device and telemedicine bridge between patient and provider, using a companion digital therapeutics (DTx) for COPD could help improve patient outcomes. The DTx is clinically-validated, works with medications, tracks triggers that reduce oxygen levels, and helps adjust key behaviors to optimize overall condition. Due to the insights provided via the DTx, COPD patients can avoid taking walks on days with high levels of air pollution, lower the use of rescue inhalers, understand how to best exercise, and experience reduced dyspnoea episodes.
The combination of device, telemedicine, and DTx is a suite of technologies composing DHT that can help patients and providers co-create care plans that help identify goals and well-defined actions to improve health and change key behaviors. While patients can still check in every 6 months with providers, data is being delivered more frequently which could reduce hospital visits and deliver better health indicators.
However, dumping large amounts of patient vitals every day is not the answer, which is why providers can enable a series of alerts that initiate a clinician review based on patient triggers revolving around personal conditions and health history. In this case, doctors only see the information that is needed, not daily dumps of data.
Who are the DHT minds behind this article?
Babylon Health
Babylon Health is a globally leading technology company with the ambitious mission to put an accessible and affordable health service in the hands of every person on Earth. We combine technology and medical expertise to bring doctors and people closer together, with digital health tools designed to empower people with knowledge about their health. Through a range of digital health services — such as an AI-backed app and video doctor appointments — we provide around-the-clock access to affordable, holistic healthcare services and information. We work with governments, health providers and insurers across the globe, and healthcare facilities from small local practices to large hospitals. With a $2Bn valuation, Babylon covers 20 million people across the globe, and has delivered more than 8m virtual consultations and AI interactions. We have teamed up with 170 impactful worldwide partners — including Mount Sinai Health Partners, the NHS, Telus Health, the Bill & Melinda Gates Foundation and the Government of Rwanda — to fulfil our vision of accessible and affordable healthcare, for all. For more information, visit https://www.babylonhealth.com
Withings
Withings produces medical grade devices for at-home monitoring so that patients can understand with precision their symptoms and trends in indicators. Withings’ mission is to continuously and effortlessly provide healthcare professionals with medical-grade data generated by patients from an ecosystem of connected devices. For more than a decade, Withings has built a range of award-winning products including activity trackers, connected scales, a wireless blood pressure monitor, a smart temporal thermometer, and an advanced sleep system. From remote patient monitoring to clinical research to chronic disease management, Withings has dedicated solutions that provide the richest array of accurate real-world data thanks to a complete ecosystem of connected devices, data connectivity options, and a remote patient monitoring platform. Visit our website here.
Digital Therapeutics Alliance
Founded in 2017, the Digital Therapeutics Alliance (DTA) is a non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. DTA maintains an international industry focus and is headquartered in the United States. DTA exists to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare through education, advocacy, and research. In Europe, digital therapeutics offer regulated, CE marked digital therapies to patients with a diagnosed condition or disease. Most DTx products in Europe require third-party authorization or a prescription from a qualified clinician. Digital therapeutics undergo clinical trials, collect real world outcomes, and are based on patient-centered core principles and product development best practices, including product design, usability, data security, and privacy standards.
[post_title] => Evolution of the digital health spectrum of care
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => evolution-of-the-digital-health-spectrum-of-care
[to_ping] =>
[pinged] =>
[post_modified] => 2023-08-04 00:02:55
[post_modified_gmt] => 2023-08-04 00:02:55
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://withingshealthsolutions.com/?p=361
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 3
[max_num_pages] => 1
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] =>
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] => 1
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 1280c3954e10c05f8c94e18894dbca1c
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
